Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
affitope pd01a (1 trial)
affitope pd03a (2 trials)
aluminum hydroxide (Gaviscon) (1 trial)
contraloid (2 trials)
Alzheimer Disease (Phase 1)
Atrophy (Phase 1)
Multiple System Atrophy (Phase 1)
Neurodegenerative Diseases (Phase 1)
Parkinson Disease (Phase 1)
Shy-Drager Syndrome (Phase 1)
Trials (4 total)
Trial APIs (4 total)